Akademisyen
ELVAN ALPER ŞENGÜL
PROFESÖR
DEMİROĞLU BİLİM ÜNİVERSİTESİ TIP FAKÜLTESİ CERRAHİ TIP BİLİMLERİ BÖLÜMÜ
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 49
- Proje 0
- Kitap 2
- Bildiri 105
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
6
Q2
11
Q3
0
Q4
6
WoS (JCR)
Q1
1
Q2
7
Q3
9
Q4
3
TR Index
2
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
2
Ort. yüzdelik
63.2%
Üst %1 payı
0.0%
Üst %10 payı
8.3%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2019 A modified method for punctoplasty: “Excisional punctoplasty with the guidance of a 27 G Rycroft cannula” YÖKSİS OpenAlex 2.2%
- 2018 Anatomical and functional outcomes of one year of intravitreal ranibizumab and aflibercept injections: Real-life data YÖKSİS OpenAlex 5.4%
- 2018 Pharmacogenetic Aspect of Intravitreal Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Five-Year Follow-Up YÖKSİS SJR Q2 JCR Q2 OpenAlex 64.1%
- 2017 Correlation of neutrophil/lymphocyte and platelet/lymphocyte ratio with visual acuity and macular thickness in age-related macular degeneration YÖKSİS SJR Q2 JCR Q4 OpenAlex 74.5%
- 2017 Short-term effects of intravitreal ranibizumab and bevacizumab administration on 24-h ambulatory blood pressure monitoring recordings in normotensive patients with age-related macular degeneration YÖKSİS SJR Q1 JCR Q2 OpenAlex 83.6%
- 2016 Retinal Nerve Fiber Layer Thickness Changes in Age-Related Macular Degeneration Treated with Multiple Intravitreal Ranibizumab YÖKSİS OpenAlex 76.6%
- 2016 Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Central Retinal Vein Occlusion: Six Months Results YÖKSİS OpenAlex 3.1%
- 2014 The Decrease in Aqueous Tear Production Associated with Pepper Spray YÖKSİS SJR Q1 JCR Q3 OpenAlex 65.0%
- 2012 İntravitreal Enjeksiyon Sonrasında Vitreus İçinde Gözlenen Silikon Yağı Damlacıklı Olgulara Yaklaşımımız YÖKSİS TR Index SJR Q4 JCR Q3
- 2011 Central Serous Chorioretinopathy Associated with Topical Latanoprost Therapy YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.3%
- 2011 COMBINATION TREATMENT WITH INTRAVITREAL INJECTION OF RANIBIZUMAB AND REDUCED FLUENCE PHOTODYNAMIC THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS YÖKSİS SJR Q1 JCR Q1 OpenAlex 75.6%
- 2010 Bimatoprost 0.03% Versus Brimonidine 0.2% in the Prevention of Intraocular Pressure Spike Following Neodymium:Yttrium–Aluminum–Garnet Laser Posterior Capsulotomy YÖKSİS SJR Q2 JCR Q2 OpenAlex 64.6%
- 2010 Posterior Reversible Encephalopathy Syndrome After Intravitreal Bevacizumab Injection in Patient with Choroidal Neovascular Membrane Secondary to Age-Related Maculopathy YÖKSİS SJR Q2 JCR Q2 OpenAlex 74.4%
- 2010 Intravitreal Bevacizumab in Treatment of Idiopathic Persistent Central Serous Chorioretinopathy: A Prospective, Controlled Clinical Study YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 98.3%
- 2009 Intravitreal Ranibizumab in the Treatment of Cystoid Macular Edema Associated With Retinitis Pigmentosa YÖKSİS SJR Q2 JCR Q3 OpenAlex 85.1%
- 2009 Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma YÖKSİS SJR Q2 JCR Q4 OpenAlex 76.0%
- 2009 Simultaneous Intravitreal and Intracameral Injection of Bevacizumab (Avastin) in Neovascular Glaucoma YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.3%
- 2009 Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.1%
- 2009 Intravitreal Bevacizumab (Avastin) Injection in Retinitis Pigmentosa YÖKSİS SJR Q2 JCR Q3 OpenAlex 80.1%
- 2008 The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension YÖKSİS SJR Q1 JCR Q2 OpenAlex 87.8%